Arend von Stackelberg

Arend von Stackelberg

UNVERIFIED PROFILE

Are you Arend von Stackelberg?   Register this Author

Register author
Arend von Stackelberg

Arend von Stackelberg

Publications by authors named "Arend von Stackelberg"

Are you Arend von Stackelberg?   Register this Author

68Publications

2194Reads

6Profile Views

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

J Clin Oncol 2016 12 31;34(36):4381-4389. Epub 2016 Oct 31.

Arend von Stackelberg, Charité Campus Virchow, Berlin; Gerhard Zugmaier, Amgen Research (Munich), Munich; Rupert Handgretinger, University of Tübingen, Tübingen; Peter Bader, Hospital for Children and Adolescents III, University of Frankfurt, Frankfurt; Paul Gerhardt Schlegel, University Children's Hospital Würzburg, Würzburg; Arndt Borkhardt, University of Düsseldorf Medical Faculty, Düsseldorf, Germany; Franco Locatelli, Ospedale Pediatrico Bambino Gesù, Rome, University of Pavia, Pavia; Carmelo Rizzari, San Gerardo Hospital, University of Milano-Bicocca, Monza; Chiara Messina, Clinica di Oncoematologia Pediatrica, Università degli Studi di Padova, Padova, Italy; Benoît Brethon, Hôpital Robert Debré, Service Hématologie-Immunologie Pédiatrique, Paris; Gérard Michel, Hôpital de la Timone, Marseille, France; Christian M. Zwaan, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, Netherlands; Tanya M. Trippett, Memorial Sloan Kettering Cancer Center, New York, NY; Maureen M. O'Brien, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Deepa Bhojwani, Children's Hospital of Los Angeles; Kuolung Hu and Min Zhu, Amgen, Thousand Oaks, CA; Susan R. Rheingold, Children's Hospital of Philadelphia, Philadelphia, PA; Todd Michael Cooper, Seattle Children's Hospital, Seattle, WA; Phillip Barnette, Primary Children's Medical Center, Salt Lake City, UT; Steven G. DuBois, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Lia Gore, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO; and James A. Whitlock, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.67.3301
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.67.3301DOI Listing
December 2016

Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.

Eur J Cancer 2016 09 29;65:91-101. Epub 2016 Jul 29.

Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Im Neuenheimer Feld 430, Heidelberg, 69120, Germany; German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, Heidelberg, 69120, Germany; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.06.009DOI Listing
September 2016

Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis.

Pediatr Blood Cancer 2016 Apr 16;63(4):640-5. Epub 2015 Dec 16.

Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25855DOI Listing
April 2016

Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.

Nat Med 2015 Jun 11;21(6):563-71. Epub 2015 May 11.

1] Key Laboratory of Pediatric Hematology and Oncology Ministry of Health, Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [2] Pediatric Translational Medicine Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [3] Department of Pharmacology, School of Basic Medicine and Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [4] Collaborative Innovation Center of Systems Biomedicine, National Research Center for Translational Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.3840DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670083PMC
June 2015

Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.

J Clin Oncol 2015 Apr 20;33(11):1275-84. Epub 2015 Jan 20.

Peter Bader, Hermann Kreyenberg, Emilia Salzmann-Manrique, Andre M. Willasch, and Thomas E. Klingebiel, University Hospital for Children and Adolescents, Frankfurt/Main; Arend von Stackelberg and Cornelia Eckert, Children's Hospital Charité, Berlin, Berlin; Roland Meisel, Heinrich-Heine-University, Düsseldorf; Daniel Stachel, University Hospital Erlangen, Erlangen; Martin Schrappe, Julia Alten, Andre Schrauder, Christian-Albrechts-University and Medical Center Schleswig-Holstein, Kiel; Ansgar Schulz, University Medical Center, Ulm; Peter Lang, University Children's Hospital, Tuebingen; Ingo Müller, University Medical Center Hamburg-Eppendorf, Hamburg; Michael H. Albert, University Children's Hospital, Munich, Germany; and Ulrike Poetschger and Christina Peters, St Anna Children's Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.4631DOI Listing
April 2015

Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.

J Clin Oncol 2015 Apr 9;33(11):1265-74. Epub 2015 Mar 9.

Christina Peters, Susanne Matthes-Martin, and Ulrike Poetschger, St Anna Children's Hospital, Vienna, Austria; Martin Schrappe, University Medical Center Schleswig-Holstein and Christian-Albrechts-University Kiel; André Schrauder, Kinderarztpraxis am Aalborgring, Kiel; Arend von Stackelberg and Wolfram Ebell, Charité-Children's Hospital Berlin, Berlin; Peter Bader and Thomas Klingebiel, Johann Wolfgang Goethe University, Frankfurt; Peter Lang, University Hospital Tübingen, Tübingen; Karl-Walter Sykora and Martin Zimmerman, Hannover Medical School, Hannover; Johanna Schrum, University Medical Center Hamburg-Eppendorf, Hamburg; Bernhard Kremens, University Hospital Essen, Essen; Karoline Ehlert, University Clinic Greifswald, Greifswald; Michael H. Albert, Dr. von Hauner University Children's Hospital, München; Roland Meisel, University Hospital Düsseldorf, Düsseldorf; Wolfgang Holter, Children's University Hospital Erlangen, Erlangen; Brigitte Strahm, University Hospital Freiburg, Freiburg; Bernd Gruhn, University Hospital Jena, Jena; Ansgar Schulz, University Hospital Ulm, Ulm; Wilhelm Woessmann, University Clinic Giessen, Giessen, Germany; and Tayfun Gungor, University Children's Hospital Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.9747DOI Listing
April 2015

Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.

Br J Haematol 2013 Jul 18;162(1):98-106. Epub 2013 Apr 18.

Paediatric Haematology/Oncology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12348DOI Listing
July 2013

[Treatment of children and adolescents with relapsed ALL: therapy target long-term healing].

Pharm Unserer Zeit 2012 May;41(3):214-21

Kinderklinik m. S. Hämatologie/Onkologie, Campus Virchow-Klinikum, Berlin.

View Article

Download full-text PDF

Source
May 2012

Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols.

Leuk Res 2011 Oct 18;35(10):1312-20. Epub 2011 May 18.

Belarusian Research Centre for Pediatric Oncology and Hematology, Pos. Lesnoe, Minsk 223040, Belarus.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.04.013DOI Listing
October 2011

Immature platelet count: a simple parameter for distinguishing thrombocytopenia in pediatric acute lymphocytic leukemia from immune thrombocytopenia.

Pediatr Blood Cancer 2011 Oct 22;57(4):641-7. Epub 2010 Dec 22.

Department of Pediatrics, Charité - Universitätsmedizin Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22907DOI Listing
October 2011

Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.

J Clin Oncol 2009 Jul 11;27(20):3363-9. Epub 2009 May 11.

Department of Pediatric Hematology/Oncology, Children's University Hospital, Giessen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.3367DOI Listing
July 2009

High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.

Blood 2008 Mar 18;111(5):2573-80. Epub 2007 Dec 18.

Department of Pediatric Oncology/Hematology, University of Berlin (Charité Universitätsmedizin Berlin), Augustenburgerplatz 1, Berlin, Germany.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2007-07-10
Publisher Site
http://dx.doi.org/10.1182/blood-2007-07-102525DOI Listing
March 2008

Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.

Eur J Cancer 2008 Jan 5;44(2):257-68. Epub 2007 Nov 5.

Charité Universitätsmedizin Berlin, OHC, Klinik für Pädiatrie m.S. Onkologie/Hämatologie, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2007.09.019DOI Listing
January 2008

Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.

Clin Cancer Res 2006 Aug;12(15):4553-61

Department of Pediatric Oncology/Hematology, HELIOS Klinikum Berlin, Robert-Roessle-Clinic, Laboratory for Functional Genomics, Charité-Universitätsmedizin Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0235DOI Listing
August 2006

Chemokine IL-8 and chemokine receptor CXCR3 and CXCR4 gene expression in childhood acute lymphoblastic leukemia at first relapse.

J Pediatr Hematol Oncol 2006 Apr;28(4):216-20

Department of Pediatric Oncology/Hematology, Charité Medical Center, Humboldt University Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mph.0000212908.14642.a5DOI Listing
April 2006

Atypical manifestation of childhood primary cerebral lymphoma restricted to the leptomeninges.

Eur J Pediatr 2005 Oct 26;164(10):653-4. Epub 2005 Jul 26.

Department of Neuropaediatrics, Charité University Medical School, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00431-005-1734-8DOI Listing
October 2005

Expression of interleukin-10 splicing variants is a positive prognostic feature in relapsed childhood acute lymphoblastic leukemia.

J Clin Oncol 2005 May;23(13):3038-42

Institute of Laboratory Medicine and Pathobiochemistry, Charité Medical Center, Humboldt University Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.00.885DOI Listing
May 2005